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Dr Ahmed M. Abou-Zamzam, Jr (Loma Linda, Calif). I
would like to congratulate the authors on a nice presentation and
a well-written manuscript. This single-center, retrospective study
seeks to analyze the effect of tibial runoff on outcomes following
primary stenting of superficial femoral (SFA) and popliteal artery
disease. In a retrospective study of nearly 300 cases performed over
7 years, the authors have found that tibial runoff does not appear to
influence overall outcomes. Primary patency and limb salvage were
equivalent in patients with zero or one patent tibial arteries com-
pared to patients with two or three patent tibial arteries. Not
surprisingly, the Trans-Atlantic InterSociety (TASC) II classifica-
tion did predict outcome. These results agree to some degree with
numerous reports in the literature and add to the growing, and
confusing, data regarding percutaneous treatment of infrainguinal
disease. The one take-home message I can agree with is that TASC
II classification trumps outflow. I have four questions:
First, the authors have chosen to use the simplified tibial
runoff scoring system. This is pretty much a yes/no score for each
runoff vessel. At this meeting 4 years ago, the Tucson group
reported, using the more complex Society for Vascular Surgery
(SVS) scoring system, that runoff did influence outcome following
SFA stenting. Why the discrepancy in this report? Did you analyze
your data with the more complete scoring system?
Second, you have adopted a policy of primary stenting. This
study spans 7 years and undoubtedly numerous stent types. Every-
one by now has their favorite stents for the SFA.What stent did you
use, and why? Did you look at outcomes by stent types? Also, this
study included no covered stents. Do you use them?
m
yThird, your study includes a predominance of patients with
laudication. We might understand caution in treating tibial dis-
ase in patients with claudication. However, when treating limb
hreat, isn’t it tempting to intervene? Groups have suggested that if
ibial outflow is compromised, perhaps results of SFA/popliteal
nterventions would be improved with tibial interventions. When
hould tibial interventions be performed?
Fourth, finally, did you do an analysis of primary assisted and
econdary patency? How are these affected by runoff?
I enjoyed the presentation and manuscript and look forward
o your responses. Thank you
Dr Jenny J. Lee. Dr Abou-Zamzam, thank you for your
nsightful comments and thoughtful questions. I will attempt to
nswer them in order. Our data were recently reanalyzed utilizing
modified SVS scoring system and we found that runoff did not
ffect primary patency rates using either scoring method. We
urrently employ a number of different nitinol stents and have
ound them all, with the exception of the Luminexx stent, to
erform in a similar fashion. At present, we currently use covered
tents infrequently, most often as a treatment for repetitive intras-
ent stenosis. Tibial intervention was performed concurrently in
bout 6% of our patients, all of whom had tissue loss or gangrene.
unoff was graded based upon completion arteriography. In an-
wer to your final question, the focus of our paper was on primary
atency rates, and primary assisted and secondary patency rates
ere not calculated. I would like to thank the society for allowing
e to present our work and for the privilege of the floor. Thank
ou.
